1. Home
  2. STG vs MDXH Comparison

STG vs MDXH Comparison

Compare STG & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunlands Technology Group

STG

Sunlands Technology Group

N/A

Current Price

$2.98

Market Cap

50.1M

Sector

Real Estate

ML Signal

N/A

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.68

Market Cap

68.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
STG
MDXH
Founded
2003
2003
Country
China
Belgium
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
50.1M
68.7M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
STG
MDXH
Price
$2.98
$0.68
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
23.4K
16.3M
Earning Date
05-21-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.78
Revenue Next Year
N/A
$18.31
P/E Ratio
$1.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.44
$0.40
52 Week High
$8.74
$5.33

Technical Indicators

Market Signals
Indicator
STG
MDXH
Relative Strength Index (RSI) 41.34 51.94
Support Level $2.61 $0.51
Resistance Level $3.64 $1.13
Average True Range (ATR) 0.12 0.05
MACD 0.02 -0.01
Stochastic Oscillator 40.91 0.00

Price Performance

Historical Comparison
STG
MDXH

About STG Sunlands Technology Group

Sunlands Technology Group operates in China's adult online education market and adult personal interest learning market through its online platforms. The Group has a deep understanding of the educational needs of its prospective students and offers solutions to help them achieve their goals. It provides online professional courses and educational content, including interest, professional skills, professional certification preparation courses, and degree- or diploma-oriented post-secondary courses. The Group adopts a counseling-oriented sales and marketing approach to offer education solutions based on students' backgrounds and goals, delivering adult online education and personal interest learning through extensive course and content offerings.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: